Follow
Janet Anderson
Janet Anderson
GSI Environmental Inc.
Verified email at gsi-net.com
Title
Cited by
Cited by
Year
Occurrence of select perfluoroalkyl substances at US Air Force aqueous film-forming foam release sites other than fire training areas: Field validation of critical fate and …
RH Anderson, GC Long, RC Porter, JK Anderson
Perfluoroalkyl Substances in the Environment, 353-372, 2018
3922018
Environmental investigation and remediation: 1, 4-dioxane and other solvent stabilizers
TKG Mohr, W DiGuiseppi, J Hatton, J Anderson
CRC Press, 2020
3132020
Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment
RS Thomas, HJ Clewell III, BC Allen, SC Wesselkamper, NCY Wang, ...
Toxicological sciences 120 (1), 194-205, 2011
1392011
Co-occurrence of 1,4-Dioxane with Trichloroethylene in Chlorinated Solvent Groundwater Plumes at US Air Force Installations: Fact or Fiction
RH Anderson
1372012
Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells
A Sharma, CES Comstock, ES Knudsen, KH Cao, JK Hess-Wilson, ...
Cancer research 67 (13), 6192-6203, 2007
982007
Environmental sources, chemistry, fate, and transport of per‐and polyfluoroalkyl substances: State of the science, key knowledge gaps, and recommendations presented at the …
JL Guelfo, S Korzeniowski, MA Mills, J Anderson, RH Anderson, ...
Environmental Toxicology and Chemistry 40 (12), 3234-3260, 2021
942021
Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer
YB Wetherill, JK Hess-Wilson, CES Comstock, SA Shah, CR Buncher, ...
Molecular cancer therapeutics 5 (12), 3181-3190, 2006
902006
Differences between human and rat intestinal and hepatic bisphenol A glucuronidation and the influence of alamethicin on in vitro kinetic measurements
CS Mazur, JF Kenneke, JK Hess-Wilson, JC Lipscomb
Drug Metabolism and Disposition 38 (12), 2232-2238, 2010
802010
Application of a framework for grouping and mixtures toxicity assessment of PFAS: A closer examination of dose-additivity approaches
PE Goodrum, JK Anderson, AL Luz, GK Ansell
Toxicological Sciences 179 (2), 262-278, 2021
792021
Endocrine disrupting compounds and prostate cancer
JK Hess-Wilson, KE Knudsen
Cancer letters 241 (1), 1-12, 2006
722006
Perfluorohexanoic acid toxicity, part I: Development of a chronic human health toxicity value for use in risk assessment
AL Luz, JK Anderson, P Goodrum, J Durda
Regulatory Toxicology and Pharmacology 103, 41-55, 2019
612019
Unique bisphenol A transcriptome in prostate cancer: Novel effects on ERβ expression that correspond to androgen receptor mutation status
JK Hess-Wilson, SL Webb, HK Daly, YK Leung, J Boldison, ...
Environmental health perspectives 115 (11), 1646-1653, 2007
492007
Perfluorohexanoic acid toxicity, part II: Application of human health toxicity value for risk characterization
JK Anderson, AL Luz, P Goodrum, J Durda
Regulatory Toxicology and Pharmacology 103, 10-20, 2019
472019
Application of computational toxicological approaches in human health risk assessment. I. A tiered surrogate approach
NCY Wang, QJ Zhao, SC Wesselkamper, JC Lambert, D Petersen, ...
Regulatory Toxicology and Pharmacology 63 (1), 10-19, 2012
452012
Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis
JK Hess-Wilson, J Boldison, KE Weaver, KE Knudsen
Breast cancer research and treatment 96, 279-292, 2006
342006
Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts
JK Anderson, RW Brecher, IT Cousins, J DeWitt, H Fiedler, K Kannan, ...
Regulatory toxicology and pharmacology 134, 105226, 2022
322022
Surgery for Deformities of the Thoracic Wall: No more than strengthening the patient's self-esteem?
C Fortmann, C Petersen
European Journal of Pediatric Surgery 28 (04), 355-360, 2018
302018
The utility of specific IgE testing to chlorhexidine in the investigation of perioperative adverse reactions
J Anderson, M Rose, S Green, SL Fernando
Annals of Allergy, Asthma & Immunology 114 (5), 425-426. e1, 2015
292015
Bisphenol A may reduce the efficacy of androgen deprivation therapy in prostate cancer
JK Hess-Wilson
Cancer Causes & Control 20, 1029-1037, 2009
282009
Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult
JK Hess-Wilson, HK Daly, WA Zagorski, CP Montville, KE Knudsen
Cancer research 66 (24), 11998-12008, 2006
262006
The system can't perform the operation now. Try again later.
Articles 1–20